James B. Thomas

Efficacy-Performance Spirals: A Multilevel Perspective

D. Lindsley, Daniel J. Brass, James B. Thomas · Academy of Management Review · 1995 · 555 citations

Management, Organizational Behavior, Organizational Development +5

A-803467, a potent and selective Na _v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh et al. · Proceedings of the National Academy of Sciences · 2007 · 523 citations · Full text

Medicine, Neurobiology, Pharmacology +17

Anxiolytic-Like Effects of κ-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats

Allison T. Knoll, Edward G. Meloni, James B. Thomas et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 227 citations

Medicine, Neuroscience, Pharmacology +16

Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist

Ivy Carroll, James B. Thomas, Linda Dykstra et al. · European Journal of Pharmacology · 2004 · 124 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Identification of the First <i>trans</i>-(3<i>R</i>,4<i>R</i>)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity

James B. Thomas, Robert N. Atkinson, Richard B. Rothman et al. · Journal of Medicinal Chemistry · 2001 · 106 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17